The Food and Drug Administration is "finished." One of its leading boosters for accelerated approval of mediocre drugs left in a huff. Drug stocks are dropping.
Just The NewsBig Pharma gravy train hits the skids under Trump, panicking revolving-door regulators, investorsEx-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory process and provided nothing but risk and cost to Americans," Stanford pediatrics professor says.